{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:22:23Z","timestamp":1747207343893,"version":"3.40.5"},"reference-count":15,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRR"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>To determine the frequency and assess the risk of cardiovascular disease in\npatients suffering from gout.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Gout is a sign of disturbed metabolism, which is associated with cardiovascular diseases\n(CVD). Soaring mortality is associated with a lot of risk factors and comorbid conditions,\nwhich have to be dealt with the help of scientists and practitioners.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The following retrospective study included 218 patients suffering from gout according to\nthe criteria of S.L. Wallace. The risk of major coronary events was calculated via the SCORE scale.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Arterial hypertension and BMI &gt; 25 kg \/ m2 (90.8%) have prevailed among the respondents.\nIncreased level of total cholesterol (TC) was detected in 63.8% cases, decreased level of highdensity\nlipoproteins - in 71.6%, and hypertriglyceridemia - in 60.5% relevantly. 175 patients\n(80.3%) had high cardiovascular risk (estimated more than 5%). 43 (19.7%) of them had a low and\nmedium risk of developing fatal CVD (1-4%). The high share of patients suffering from gout was\nendangered with cardiovascular pathology.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The most frequently matched risk factors among patients suffering from gout are an\nincrease in BMI&gt; 25 kg\/m2 (90.8%) and dyslipidemia.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573397118666220802141420","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T13:20:41Z","timestamp":1659446441000},"page":"72-75","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk Factors of Cardiovascular Pathology in Patients with Gout"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7782-6255","authenticated-orcid":true,"given":"Abdugani","family":"Musayev","sequence":"first","affiliation":[{"name":"Department of Ambulance and Emergency Care, Kazakh National Medical University, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0368-4773","authenticated-orcid":true,"given":"Lidiya","family":"Khituova","sequence":"additional","affiliation":[{"name":"Department of Child Diseases, Kazakh National Medical University Named after S. Asfendiyarov, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venera","family":"Khabizhanova","sequence":"additional","affiliation":[{"name":"Department of General Medical Practice, Kazakh National Medical University, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1891-6773","authenticated-orcid":true,"given":"Gulsim","family":"Akhmetova","sequence":"additional","affiliation":[{"name":"Department of Ambulance and Emergency Care, Kazakh National Medical University, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2523-0895","authenticated-orcid":true,"given":"Elmira","family":"Almukhambetova","sequence":"additional","affiliation":[{"name":"Department of Ambulance and Emergency Care, Kazakh National Medical University, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6463-5273","authenticated-orcid":true,"given":"Vildan","family":"Indershiyev","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Kazakh National Medical University, Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/ar3199","volume":"12","author":"Roddy E.","year":"2010","unstructured":"Roddy E.; Doherty M.; Epidemiology of gout. Arthritis Res Ther 2010,12(6),223","journal-title":"Arthritis Res Ther"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/BOR.0000000000000141","volume":"27","author":"Nasser-Ghodsi N.","year":"2015","unstructured":"Nasser-Ghodsi N.; Harrold L.R.; Overcoming adherence issues and other barriers to optimal care in gout. Curr Opin Rheumatol 2015,27(2),134-138","journal-title":"Curr Opin Rheumatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.7326\/M16-0570","volume":"166","author":"Qaseem A.","year":"2017","unstructured":"Qaseem A.; Harris R.P.; Forciea M.A.; Management of acute and recurrent gout: a clinical practice guideline from the american college of physicians. Ann Intern Med 2017,166(1),58-68","journal-title":"Ann Intern Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.semarthrit.2014.02.003","volume":"44","author":"Khanna P.P.","year":"2014","unstructured":"Khanna P.P.; Gladue H.S.; Singh M.K.; Treatment of acute gout: A systematic review. Semin Arthritis Rheum 2014,44(1),31-38","journal-title":"Semin Arthritis Rheum"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","volume":"74","author":"Kuo C.F.","year":"2015","unstructured":"Kuo C.F.; Grainge M.J.; Mallen C.; Zhang W.; Doherty M.; Rising burden of gout in the UK but continuing suboptimal management: A nationwide population study. Ann Rheum Dis 2015,74(4),661-667","journal-title":"Ann Rheum Dis"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.7861\/clinmedicine.17-1-54","volume":"17","author":"Abhishek A.","year":"2017","unstructured":"Abhishek A.; Roddy E.; Doherty M.; Gout - a guide for the general and acute physicians. Clin Med (Lond) 2017,17(1),54-59","journal-title":"Clin Med (Lond)"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s40256-020-00459-1","volume":"21","author":"Kaul S.","year":"2021","unstructured":"Kaul S.; Gupta M.; Bandyopadhyay D.; Gout pharmacotherapy in cardiovascular diseases: A review of utility and outcomes. Am J Cardiovasc Drugs 2021,21(5),499-512","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"Richette P.","year":"2017","unstructured":"Richette P.; Doherty M.; Pascual E.; 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 2017,76(1),29-42","journal-title":"Ann Rheum Dis"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"Klionsky D.J.","year":"2016","unstructured":"Klionsky D.J.; Abdelmohsen K.; Abe A.; Abedin M.J.; Abeliovich H.; Arozena A.; Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 2016,12(1),1-222","journal-title":"Autophagy"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.36740\/WLek201907112","volume":"72","author":"Bychkov &#x41E;\u0410","year":"2019","unstructured":"Bychkov &#x41E;\u0410; Kondratiuk V.E.; Bychkova N.G.; Morozova Z.V.; Bychkova S.A.; Tarasiuk A.P.; Role of immune system in development and progress of combined arterial hypertension and gout. Wiad Lek 2019,72(7),1295-1299","journal-title":"Wiad Lek"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/BOR.0b013e3282f4b1ed","volume":"20","author":"Puig J.G.","year":"2008","unstructured":"Puig J.G.; Mart&#xED;nez M.A.; Hyperuricemia, gout and the metabolic syndrome. Curr Opin Rheumatol 2008,20(2),187-191","journal-title":"Curr Opin Rheumatol"},{"key":"ref=12","first-page":"1575","volume":"31","author":"Riedel A.A.","year":"2004","unstructured":"Riedel A.A.; Nelson M.; Joseph-Ridge N.; Wallace K.; MacDonald P.; Becker M.; Compliance with allopurinol therapy among managed care enrollees with gout: A retrospective analysis of administrative claims. J Rheumatol 2004,31(8),1575-1581","journal-title":"J Rheumatol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"582680","DOI":"10.3389\/fphar.2020.582680","volume":"11","author":"Yu W.","year":"2020","unstructured":"Yu W.; Cheng J.D.; Uric acid and cardiovascular disease: An update from molecular mechanism to clinical perspective. Front Pharmacol 2020,11,582680","journal-title":"Front Pharmacol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"e000282","DOI":"10.1136\/bmjopen-2011-000282","volume":"2","author":"Krishnan E.","year":"2012","unstructured":"Krishnan E.; Gout and the risk for incident heart failure and systolic dysfunction. BMJ Open 2012,2(1),e000282","journal-title":"BMJ Open"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/annrheumdis-2012-202421","volume":"73","author":"Perez-Ruiz F.","year":"2014","unstructured":"Perez-Ruiz F.; Mart&#xED;nez-Indart L.; Carmona L.; Herrero-Beites A.M.; Pijoan J.I.; Krishnan E.; Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout. Ann Rheum Dis 2014,73(1),177-182","journal-title":"Ann Rheum Dis"}],"container-title":["Current Rheumatology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573397118666220802141420","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/207217\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573397118666220802141420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T10:33:42Z","timestamp":1679654022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/207217\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573397118666220802141420","relation":{},"ISSN":["1573-3971"],"issn-type":[{"type":"print","value":"1573-3971"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-10-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}